To display releases by year, please select a year below and click Filter.
September 11, 2022
GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022
View Press Release
September 8, 2022
GRAIL to Present Final Multi-Cancer Early Detection Data from the Interventional PATHFINDER Study at ESMO Congress 2022
View Press Release
July 18, 2022
GRAIL and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test
View Press Release
July 12, 2022
Mercy Offers New GRAIL Blood Test to Detect 50+ Types of Cancer
View Press Release
June 28, 2022
Community Health Network and GRAIL Partner to Offer Galleri® Multi-Cancer Early Detection Test in Central Indiana
View Press Release
June 21, 2022
GRAIL and Fountain Health Insurance Partner to Provide Coverage of Galleri® Multi-Cancer Early Detection Test
View Press Release
June 6, 2022
GRAIL and England’s National Health Service (NHS) Present Trial Design for Largest Study of Multi-Cancer Early Detection Test at ASCO Annual Meeting
View Press Release
June 3, 2022
GRAIL and Ochsner Health Launch New Initiatives to Improve Cancer Detection Rates in Louisiana
View Press Release
June 2, 2022
GRAIL Announces Strategic Collaboration with AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer
View Press Release
May 31, 2022
GRAIL Announces Collaboration with U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test
View Press Release
Displaying 51 - 60 of 78